Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Quick Google for P2 ready asset is 86% discount and because 1801 is ready, it would mean 1802 is almost ready. Just some preclinical work to do. So the valuation would be based on 2 x TYK compounds and 27% share in 737. There might also be some value in the Skil platform but I think Aurora/fkt3 is shelved for the foreseeable. Do make your own mind up. All time highs would seem very cheap IMO.
Yep, I'm not happy with the dillution but I already sorted that. I agree with Damion. This feels like the last roll of the dice. The switching from 1b to 2a will require more funding for the trial design and trial and that will mean another place or 737 to come good. We'd need the likes of RMM to do a value analysis to work out a value for a TO based on a successful P1.
Aber, maybe that's all he can afford. He gets a decent salary but we all live up to what we can afford. I work for a living as do lost here but most of my investments are locked away do I dont have the option to liquidate anything so for me, my extra buys are from my disposable income slush fund. Maybe JR is in the sane boat.
Made me laugh this, Kat. I've always done this and I'm not sure why others don't. I once had a glorious run on PYC, for about 3 weeks. I was riding the daily fluctuaions. Making approx £200 a day. No much but was £3k richer for not doing anything. Use the volitity to your benefit. When I had an AIM portfolio. I aimed for £250 a week profit. Again not much but that was a pretty easy £12k a year added to my pot. You don't need a system just a simple spreadsheet. Ticker, date, buy price. That's all I use and for the shorting trolls. Thats why I've been buying the way down. I know I can sell a big chunk on the way back up and I know when to sell in profit.
I've traded SAR for 12 years. Sold out completely twice and taken profit via top slicing many times. I've increased my pot by 30% this week and have a record of the buys. If we see a spike on 1a data, I will top slice again. My main pot is 50k shares and I've got around 17k shares on top of that to play with. My SAR shares own me nothing so I'm just playing the game now and have been for 3 years or so.
I've no problem with shorters. If it's legal, then it's fair game and at least someone is making money. It's also nice to troll the so called saviors, those who are trying to save us money. Well, I'm a lost cause. I said earlier, I will keep buying while under a pound. I increased my pot by 20% this week. So the dillution is now covered. I will take part in the placing too, just for the lolz. And if your really are going to Disney land, hope you have a great time. We'll probably not see you until Tue, you know because it's, "family time". I wouldn't be looking at my phone if with my kids. Not worth the time you lose with them. Live in the moment, health, family and friends are more important.
I love reading Advfn for fun. I love that I/we can live rent free in their heads. So much of their time spent repeating what is said on here. And for the advfn guys. I don't know what is going to happen. I've bought anyway and you know, it might just turn out great. I'm a free rider BTW, like a lot if the LTH so, technically, I will have lost nothing.
If the UK government was serious about supporting UK businesses and startups. They'd clean up AIM. No shorting, access to government unwritten short-term loans, better tax breaks and better protection for shareholders. The threat of prison for dodgy directors should sort that one.
And I know I had a go at Parker this morning saying he was a wheeler dealer. Having said that I do hope he's had his best Del Boy outfit on these last two weeks, cruising around the City in his Reliant Robin trying to get his mates to stump up a couple of ponies.
All we need to worry about is securing enough funding to progress to p1a data readout. Hopefully the board can secure funding that offers the least amount of dilution as possible but I think we'll have to accept some level of dilution.
To add to my list. and i'm not an expert here, not even an amateur but say we take the lowest deal on the list circa 4 billion for a stage 2 asset. And a pharma only gives us a 10% chance of getting to market. Then even with a 90% discount. We're still looking at £400 million. The thing is if phase 1b is a success and shows a good immune response. The discount on good p1b data is considerably smaller. If we can't raise funds on the back of that sort of potential, we may as well just call it a day. This why some lth are still buying because if the board pull it off. It will be a legendary return from these levels.
Not my list, can't remember who posted it but these are the size of deals we can expect if we get to phase 2 or 3.
Pfizer and Seagen. Deal size $43 Billion
2. Bristol Myers Squibb and Karuna Therapeutics Deal size $14 Billion
3. Merck and Prometheus Biosciences Deal size $10.8 Billion
4. AbbVie and ImmunoGen Deal size $10.1 Billion
5. AbbVie and Cerevel Therapeutics $8.7 Billion
6. Biogen and Reata Pharmaceuticals Deal size $7.3 Billion
7. Roche and Telavant Deal size $7.1 Billion
8. Astellas and Iveric Bio Deal size £5.9 Billion
9. Bristol Myers Squibb and Mirati Therapeutics Deal size $4.8 Billion
10. Bristol Myers Squibb and RayzeBio Deal size $4.1 Billion